Enterprise Value
11.21M
Cash
3.224M
Avg Qtr Burn
-2.893M
Short % of Float
3.80%
Insider Ownership
1.93%
Institutional Own.
11.74%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
186RNL™ (BMEDA-Chelated Rhenium NanoLiposome) Details Glioblastoma, Cancer | Phase 2 Update | |
186RNL™ (BMEDA-Chelated Rhenium NanoLiposome) Details Cancer, Breast cancer | Phase 1/2 Update |